Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jun 18, 2021 (5 years ago)

Topotecan Injection 4 mg/4mL

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceuticals USA, Inc. North Whales, PA 19454, Carton NDC# 0703-4714-01, Vial NDC# 0703-4714-71

Affected NDCs 0703-4714-01 0703-4714-71

Compare with the code on your package — it is the most precise check available.

Recalling firm
Teva Pharmaceuticals USA
NDC code
0703-4714-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0661-2021 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Teva Pharmaceuticals USA

All 2021 recalls

Other particulate / foreign matter recalls from 2021

All particulate / foreign matter recalls
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022